CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice

M Poggi, SO Morin, D Bastelica, R Govers… - International Journal of …, 2015 - nature.com
M Poggi, SO Morin, D Bastelica, R Govers, M Canault, D Bernot, O Georgelin, M Verdier…
International Journal of Obesity, 2015nature.com
Methods: During diet-induced obesity, we investigated the effects of selective interference
with CD28 signaling using knockout mice (Cd28KO) and a CTLA4-Ig fusion protein
inhibiting CD28-B7 interactions. Results: Cd28 deficiency decreased pathogenic T cells and
Treg content within AT without changing the macrophages number. Cd28KO epididymal but
not subcutaneous fat was characterized by enlarged adipocytes, reduced levels of
inflammatory cytokines and increased Glut4, adiponectin and lipogenic enzyme mRNA …
Methods:
During diet-induced obesity, we investigated the effects of selective interference with CD28 signaling using knockout mice (Cd28KO) and a CTLA4-Ig fusion protein inhibiting CD28-B7 interactions.
Results:
Cd28 deficiency decreased pathogenic T cells and Treg content within AT without changing the macrophages number. Cd28KO epididymal but not subcutaneous fat was characterized by enlarged adipocytes, reduced levels of inflammatory cytokines and increased Glut4, adiponectin and lipogenic enzyme mRNA levels. This was associated with reduced inflammation, fat accumulation and enhanced glucose metabolism in liver. Weight gain and fasting glucose tolerance were not affected. CTLA4-Ig injections reduced the number of T cells in epididymal AT (epiAT) but not the inflammatory cytokines levels and failed to improve liver fat accumulation.
Conclusions:
Deletion of CD28 creates a new pro/anti-inflammatory balance in epiAT and liver and exerts a protective effect against hepatic steatosis.
nature.com